Artelo Biosciences (ARTL) Short-term Investments (2018 - 2024)
Artelo Biosciences (ARTL) posted quarterly Short-term Investments of $500000.0 for Q3 2024, down 89.41% quarter-over-quarter from $4.7 million in Q2 2024.
Artelo Biosciences (ARTL) Short-term Investments (2018 - 2024) Analysis & Trends
Artelo Biosciences (ARTL) has reported Short-term Investments for 7 consecutive years, with $500000.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Short-term Investments changed N/A year-over-year to $500000.0; the TTM figure through Sep 2024 stood at $500000.0 (changed N/A YoY), while the FY2023 annual figure was $7.6 million, up 409.1% from the prior year.
- Short-term Investments fell to $500000.0 in Q3 2024 per ARTL's latest filing, from $4.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $12.3 million in Q4 2021 and bottomed at $1500.0 in Q1 2020.
- Historically, Short-term Investments has averaged $3.7 million across 5 years, with a median of $1.7 million in 2022.
- Annual changes were most pronounced in 2021 — Short-term Investments surged 34035.33% — and 2023, when it soared 409.1%.
- Artelo Biosciences' Short-term Investments stood at $1500.0 in 2020, then soared by 821100.0% to $12.3 million in 2021, then slumped by 87.86% to $1.5 million in 2022, then jumped by 409.1% to $7.6 million in 2023, then sank by 93.43% to $500000.0 in 2024.
- Business Quant data shows ARTL's Short-term Investments at $500000.0 in Q3 2024, $4.7 million in Q2 2024, and $6.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 4.72 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 7.61 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 2.00 Mn |
| Nov 30, 2021 | 12.32 Mn |
| Feb 28, 2021 | 512,030.00 |
| Feb 29, 2020 | 1,500.00 |
| Nov 30, 2019 | 1,500.00 |
| Aug 31, 2019 | 1,500.00 |
| May 31, 2019 | 540,917.00 |
| Aug 31, 2018 | 1,500.00 |